Nektar Therapeutics
Price & Volume
Stats
See more52W Range | $0.48-$1.92 |
Market Cap | $171.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $93.1M |
Revenue Growth (YoY) | -0.1% |
Gross Profit (12 Mos) | $70.4M |
Diluted EPS | -$0.84 |
News
See moreYahoo Finance • 5 months ago
Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week
Yahoo Finance • 10 months ago
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
Yahoo Finance • 10 months ago
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
Yahoo Finance • 12 months ago
Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners
About
CEO | Mr. Howard W. Robin |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 137 |
